Cormorant Asset Management, LP is 10% Owner at EyePoint, Inc. (EYPT). They have made 18 open-market trades across 12 companies since 2018, most recently 2026-04-28.
16 open-market purchases totalling $209.8M since 2018, against 2 sales. Across 16 scored buys the stock is up 9.8% at ninety days, and 4.4 points ahead of the S&P over the same stretch.
16 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 44% | 56% |
| Avg Move | -2.2% | +1.5% | +9.8% |
| Alpha | -3.2% | -0.9% | +4.4% |
| Scored | 16 | 16 | 16 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DRUG | SELL | 2026-04-28 | 2026-04-30 | $89.50 | $9.8M | -4.0% | -8.2% | -19.6% |
| EYPT | SELL | 2025-12-04 | 2025-12-08 | $15.70 | $942K | -3.0% | -1.2% | -10.9% |
| DRUG | BUY | 2024-11-04 | 2024-11-06 | $21.70 | $8.0M | -34.3% | -30.5% | -32.1% |
| EYPT | BUY | 2024-05-06 | 2024-05-08 | $11.86 | $20.2M | -1.6% | -26.3% | -26.9% |
| CRBP | BUY | 2024-02-02 | 2024-02-06 | $19.00 | $14.3M | -13.5% | +51.0% | +45.4% |
| EYPT | BUY | 2024-01-09 | 2024-01-11 | $19.94 | $17.1M | +12.5% | +39.6% | +2.0% |
| EYPT | BUY | 2023-12-08 | 2023-12-12 | $17.00 | $10.0M | +15.0% | +3.7% | +16.4% |
| AMAM | BUY | 2023-10-23 | 2023-10-25 | $6.99 | $18.3M | -3.8% | -5.7% | +167.8% |
| AMAM | BUY | 2023-09-15 | 2023-09-19 | $9.12 | $39.3M | -5.7% | -26.2% | +20.7% |
| ERAS | BUY | 2022-12-13 | 2022-12-21 | $6.50 | $2.0M | +7.0% | -7.5% | -24.6% |
| PYXS | BUY | 2021-10-13 | 2021-10-15 | $16.00 | $7.2M | +8.3% | +0.5% | -16.4% |
| IMRX | BUY | 2021-08-03 | 2021-08-05 | $15.00 | $8.3M | +9.4% | -7.8% | +7.7% |
| ERAS | BUY | 2021-07-20 | 2021-07-22 | $16.00 | $15.2M | +1.5% | +5.4% | -2.7% |
| GLUE | BUY | 2021-06-28 | 2021-06-30 | $19.00 | $11.4M | -18.5% | +7.5% | +4.2% |
| BMEA | BUY | 2021-04-20 | 2021-04-22 | $17.00 | $15.3M | -5.8% | -2.8% | -25.7% |
| DSGN | BUY | 2021-03-30 | 2021-04-01 | $20.00 | $15.0M | -22.7% | -8.4% | -33.7% |
| TPTX | BUY | 2019-04-22 | 2019-04-25 | $18.00 | $7.2M | +14.4% | +36.4% | +34.6% |
| KNSA | BUY | 2018-05-29 | 2018-05-31 | $18.00 | $1.2M | +2.0% | -5.2% | +20.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| GLUE | 2,602,200 | $25.4M |
| EYPT | 8,265,000 | $24.7M |
| CRBP | 1,475,000 | $6.6M |
| IMRX | 1,702,628 | $6.1M |
| BMEA | 2,270,872 | $2.0M |
| PYXS | 668,854 | $1.1M |
| Total | $949.6M |
Shares reported on the most recent Form 4, priced at the 2026-04-30 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.